Michael Douglas has considerable experience performing systematic reviews for AHRQ, CDC and at BCBSA and extensive experience in molecular biology techniques and coordinating projects. His career has focused on the public health field since 1999 and has spent the past 6 years in Public Health Genomics at the Centers for Disease Control and Prevention. Michael is the program coordinator for the Office of Public Health Genomics Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative where he is involved in coordinating a team of volunteer working group members who focus on developing methods to evaluate Genomic Tests, commissioning evidence-based reviews, and writing recommendation statements for these reviews. He has been part of several evidence-based reviews for the initiative and is currently conducting a review on Type 2 Diabetes Risk Assessment. In addition to his work in the Public Health Genomics office, he has joined the BCBSA Technical Evaluation Center, as a contingent research associate, and participated in several AHRQ evidence reviews, and in addition to working on Medical Policy Guidelines.
Michael received his B.S. degree in Biology from the College of Environmental Science and Forestry, Syracuse, New York and a M.S. degree in Molecular Biology from the same institution. He has worked in Plant Genetics and Infectious Disease at Cornell University, Ithaca, New York and Molecular Diagnostics at Bayer Diagnostics, Tarrytown, New York.